261 related articles for article (PubMed ID: 29791013)
1. Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14
Jaureguiberry-Bravo M; Lopez L; Berman JW
J Leukoc Biol; 2018 Dec; 104(6):1049-1059. PubMed ID: 29791013
[TBL] [Abstract][Full Text] [Related]
2. Frontline Science: CXCR7 mediates CD14
Veenstra M; Williams DW; Calderon TM; Anastos K; Morgello S; Berman JW
J Leukoc Biol; 2017 Nov; 102(5):1173-1185. PubMed ID: 28754798
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of CNS Viral Seeding by HIV
Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis.
Williams DW; Calderon TM; Lopez L; Carvallo-Torres L; Gaskill PJ; Eugenin EA; Morgello S; Berman JW
PLoS One; 2013; 8(7):e69270. PubMed ID: 23922698
[TBL] [Abstract][Full Text] [Related]
5. Dopamine Increases CD14
Calderon TM; Williams DW; Lopez L; Eugenin EA; Cheney L; Gaskill PJ; Veenstra M; Anastos K; Morgello S; Berman JW
J Neuroimmune Pharmacol; 2017 Jun; 12(2):353-370. PubMed ID: 28133717
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine decreases the CCL2-mediated chemotactic response of monocytes.
Carvallo L; Lopez L; Che FY; Lim J; Eugenin EA; Williams DW; Nieves E; Calderon TM; Madrid-Aliste C; Fiser A; Weiss L; Angeletti RH; Berman JW
J Immunol; 2015 Apr; 194(7):3246-58. PubMed ID: 25716997
[TBL] [Abstract][Full Text] [Related]
7. Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS.
Buckner CM; Calderon TM; Willams DW; Belbin TJ; Berman JW
Cell Immunol; 2011; 267(2):109-23. PubMed ID: 21292246
[TBL] [Abstract][Full Text] [Related]
8. Dopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesis.
Coley JS; Calderon TM; Gaskill PJ; Eugenin EA; Berman JW
PLoS One; 2015; 10(2):e0117450. PubMed ID: 25647501
[TBL] [Abstract][Full Text] [Related]
9. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals.
Williams DW; Anastos K; Morgello S; Berman JW
J Leukoc Biol; 2015 Feb; 97(2):401-12. PubMed ID: 25420915
[TBL] [Abstract][Full Text] [Related]
10. Treatment with buprenorphine prior to EcoHIV infection of mice prevents the development of neurocognitive impairment.
Jaureguiberry-Bravo M; Kelschenbach J; Murphy A; Carvallo L; Hadas E; Tesfa L; Scott TM; Rivera-Mindt M; Cunningham CO; Arnsten JH; Volsky DJ; Berman JW
J Leukoc Biol; 2021 Mar; 109(3):675-681. PubMed ID: 32578908
[TBL] [Abstract][Full Text] [Related]
11. Central Nervous System (CNS) Viral Seeding by Mature Monocytes and Potential Therapies To Reduce CNS Viral Reservoirs in the cART Era.
León-Rivera R; Veenstra M; Donoso M; Tell E; Eugenin EA; Morgello S; Berman JW
mBio; 2021 Mar; 12(2):. PubMed ID: 33727362
[TBL] [Abstract][Full Text] [Related]
12. Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders.
Yadav A; Betts MR; Collman RG
J Neurovirol; 2016 Oct; 22(5):584-596. PubMed ID: 27021071
[TBL] [Abstract][Full Text] [Related]
13. CCR2 on Peripheral Blood CD14
Veenstra M; Byrd DA; Inglese M; Buyukturkoglu K; Williams DW; Fleysher L; Li M; Gama L; León-Rivera R; Calderon TM; Clements JE; Morgello S; Berman JW
J Neuroimmune Pharmacol; 2019 Mar; 14(1):120-133. PubMed ID: 29981000
[TBL] [Abstract][Full Text] [Related]
14. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.
Eugenin EA; Osiecki K; Lopez L; Goldstein H; Calderon TM; Berman JW
J Neurosci; 2006 Jan; 26(4):1098-106. PubMed ID: 16436595
[TBL] [Abstract][Full Text] [Related]
15. Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS.
Eugenin EA; Gamss R; Buckner C; Buono D; Klein RS; Schoenbaum EE; Calderon TM; Berman JW
J Leukoc Biol; 2006 Mar; 79(3):444-52. PubMed ID: 16507710
[TBL] [Abstract][Full Text] [Related]
16. Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders.
Williams DW; Veenstra M; Gaskill PJ; Morgello S; Calderon TM; Berman JW
Curr HIV Res; 2014; 12(2):85-96. PubMed ID: 24862333
[TBL] [Abstract][Full Text] [Related]
17. Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.
Jaureguiberry-Bravo M; Wilson R; Carvallo L; Berman JW
Curr HIV Res; 2016; 14(5):417-430. PubMed ID: 27009099
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Opioids on HIV Neuropathogenesis.
Murphy A; Barbaro J; Martínez-Aguado P; Chilunda V; Jaureguiberry-Bravo M; Berman JW
Front Immunol; 2019; 10():2445. PubMed ID: 31681322
[TBL] [Abstract][Full Text] [Related]
19. Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis.
Williams DW; Eugenin EA; Calderon TM; Berman JW
J Leukoc Biol; 2012 Mar; 91(3):401-15. PubMed ID: 22227964
[TBL] [Abstract][Full Text] [Related]
20. Selective expansion of pro-inflammatory chemokine CCL2-loaded CD14+CD16+ monocytes subset in HIV-infected therapy naïve individuals.
Ansari AW; Meyer-Olson D; Schmidt RE
J Clin Immunol; 2013 Jan; 33(1):302-6. PubMed ID: 22961048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
